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Pathogenic E. coli cause intestinal or extraintestinal infections in many host 
species. E. coli strains enter the intestinal tract through food and colonize the 
intestinal epithelium to cause infections. In animals and humans, E. coli causes 
gastroenteritis, neonatal meningitis and urinary tract infections. In birds, E. coli 
causes a complex syndrome called avian colibacillosis.  
 
The orthologs of BarA-UvrY two-component (TCS) system is known to 
regulate a number of phenotypic traits in gamma proteobacteria, although their role in 
Extraintestinal pathogenic Escherichia coli (ExPEC) virulence is yet to be 
determined. The barA gene is membrane bound sensor kinase protein and the uvrY 
gene encodes the cognate response regulator in E. coli. Work in this study has 
focused how the BarA-UvrY and LuxS system regulates in vivo virulence in 
uropathogenic E. coli (UPEC) and avian pathogenic E. coli (APEC) during infection. 
  
The main goal of this study is to look at how BarA-UvrY TCS and LuxS regulate 
virulence in APEC χ7122 and UPEC CFT073.  In this study, we studied the role of 
BarA-UvrY TCS system in regulation of virulence in the aforementioned ExPEC 
strains using animal model and tissue culture system and the role of LuxS in 
regulation of virulence determination in ExPEC. Our results indicate that BarA-UvrY 
regulates multiple virulence properties in APEC χ7122 and UPEC CFT073 and that 
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  CHAPTER 1 
Introduction 
1.1. Background 
1.1.1. Escherichia coli, a pathogen 
E. coli is a gram negative, rod shaped bacterium found in the intestinal tracts of 
aquatic, avian, warm blooded animals and humans. It is a facultative anaerobe and adapts 
to its intestinal (anaerobic) and extraintestinal (aerobic or micro  aerophilic) habitats.  In 
humans and animals, pathogenic E. coli causes both intestinal and extraintestinal 
infections (1).  Extraintestinal pathogenic E. coli, such as avian pathogenic E. coli 
(APEC), uropathogenic E. coli (UPEC) and neonatal meningitis E. coli (NMEC), causes 
extraintestinal infections in different hosts (2). 
 
1.1.2. Avian pathogenic E. coli  
Infection with APEC causes avian colibacillosis, which is characterized by air 
sacculitis, pericarditis, peritonitis, salpingitis, polyserositis, septicemia, synovitis, 
osteomyelitis, and yolk sac infection (3).  APEC strains are responsible for huge 
economic losses to the poultry industry due to mortality and carcass condemnations (4). 
The infection results in loss of over 40 million dollars per year to the U.S. poultry 
industry (5).  APEC strains infect respiratory tract of chickens, turkeys, ducks and 






to O1, O2 and O78 serogroups (6, 3, 7).                                                       
 
1.1.3. Uropathogenic E. coli  
Urinary tract infection (UTI) is considered to be the most common bacterial 
infectious disease of humans (8). UTI accounts for 7 million office visits resulting in 
100,000 hospitalizations and costs approximately $ 1.6 billion per year in the United 
States alone (9). UTI is one of the most common problems in young women causing 
morbidity in medical attention and health care costs. UPEC is the main cause of 
community-acquired UTIs in women (10). UTI is more common among women than 
man and 40% to 50% of women will experience at least one UTI during their lifetime (9).  
In healthy individuals up to 90% of uncomplicated UTI is caused by UPEC (11). UTI is 
most often caused by ascending bacterial infection contaminating the periurethral area 
from the lower intestinal tract, then colonizing the bladder via the urethra, causing 
cystitis, and in severe cases, infecting the kidneys via the ureters resulting in 
pyelonephritis (12). UPEC is distinct from the intestinal pathogenic E. coli in that UPEC 
has to enter urinary tract to establish infection. Extraintestinal E. coli isolates possess 
genes coding for various virulence factors like adhesions (eg. type 1, P, S), iron 
acquisition system (eg. aerobactin, enterobactin, but not limited to these systems), host 
defense avoidance mechanisms (eg. capsule, O-specific antigen, oxidative stress response 






1.1.4. Two component signal transduction system 
Bacteria often utilize signaling systems to respond to the drastic changes in the 
extracellular environment. The two-component signal (TCS) transduction system forms a 
major signal-transduction pathway in prokaryotes that involve adaptation to the 
environmental signals and it regulates gene expression and/or protein function (15). TCS 
have two conserved proteins, the histidine protein kinase (HK) and the response regulator 
protein (RR) constituting the phosphotransfer signaling pathway (16). The histidine 
residue of the conserved HK is autophosphorylated to produce a high energy phosphoryl 
group. The phosphotransfer from the phospho-histidine of the HK to aspartic acid side 
chain of the RR is catalyzed by protein dimerization, creating a high energy acyl-
phosphate that activates the RR. The level of the phosphorylated RR determines the 
output response of the TCS (15).  
 
1.1.5. BarA-UvrY TCS in E. coli 
In several pathogenic gamma proteobacteria, BarA protein (Bacterial Adaptive Response 
Protein) functions as conserved membrane associated sensor kinase protein (17, 18). 
Mutations in the  barA gene, encoding BarA, exhibit sensitivity to oxidative stress due to 
impairment in catalase expression (19, 20). The cognate response regulator for BarA 
protein is  UvrY protein and orthologs of uvrY encoding gene are present in other 
bacterial species like gacA in Pseudomonas, sirA in salmonella, varA in vibrio and expA 
in Erwinia (21, 22, 23, 24). Environmental magnesium concentration was a potent 




fatty acids and bile alter gene expression and virulence of BarA-SirA two-component 
system of Salmonella (26, 27).  
 In E. coli, BarA-UvrY Two Component System (TCS) regulate the expression of 
csrB and csrC non coding regulatory RNA, which in turn titrates the activity of CsrA 
global RNA binding protein. Secondary stem loop structure of csrB and csrC RNA binds 
to CsrA protein and prevents it from binding to 5’ untranslated leader sequences of 
mRNA. CsrA is known to exert its post-transcriptional regulation for genes involved in 
carbon metabolism, flagellar biosynthesis and biofilm formation (28, 29, 24, 30). 
The orthologs of BarA-UvrY TCS in other gram negative γ-proteobacterial 
species are BarA-SirA of Salmonella enterica (24), ExpS-ExpA of Erwinia carotovora 
(31), VarS-VarA of Vibrio cholerae (32), and GacS-GacA of Pseudomonas species (31). 
The disruption of these two component systems in these bacteria leads to reduction in 
their virulence.  In this study, we investigated the hypothesis that the BarA-UvrY 
TCS is critical to the virulence of APEC O78:K80:H9 and UPEC CFT073.  
 
 1.1.6. Quorum sensing in E. coli 
Quorum sensing is a bacterial cell-cell communication via the production of small 
signaling molecule in a population density-dependent manner. LuxS, the S-
ribosylhomocysteine (SRH) cleavage enzyme, has an important metabolic function in the 
activated methyl cycle, namely the recycling of S-adenosylhomocysteine (SAH) to  
homocysteine (33). By-products of methyl cycle produce a furanone, called autoinducer- 




quorum sensing (QS) (34).  LuxS a highly conserved autoinducer synthase is present in 
some Gram positive and Gram negative bacterial species (35).  This autoinducer is 
involved in quorum sensing (34).  
In enteroheamorrhagic E. coli (EHEC) and enteropathogenic E. coli (EPEC), luxS 
quorum sensing system activated the transcription locus of enterocyte effacement genes, 
which are involved in expressing factors and in establishing an infection (36). In EPEC, 
mutation in the  luxS gene leads to diminished Type III secretion. The defect in the Type 
III secretion system attributed to partial reduction in attachment and effacing (AE) lesions 
on cultured HeLa epithelial cells (37).  In a mouse model, mutation in luxS gene of 
Streptococcus pneumoniae displayed partial reduction in virulence compared to its wild 
type (37). In Vibrio vulnificus, luxS mutation resulted in reduced cytotoxicity activity in 
cultured HeLa cells and attenuation of lethality in mice. Also deletion of luxS in 
Neisseria meningitidis caused defective bacteremia and reduced meningococcal virulence 
(38).  Thus, Quorum sensing has been involved in virulence gene expression (39), biofilm 
formation (40) and motility (41).  In this present study, we also examined the role of 










The main goal of this study is to look at how BarA-UvrY two-component system 
(TCS) and LuxS regulate virulence in APEC χ7122 and UPEC CFT073. To study the role 
of BarA-UvrY TCS  and that of LuxS in regulation of virulence in ExPEC using animal model 
and tissue culture system were used to understand the regulation of virulence 
determination in ExPEC.  
 
1.2.1. Avian Pathogenic Escherichia coli 
 Regulation of virulence using in vivo method includes infection of specific 
pathogen free (SPF) eggs with various bacterial strains to study the effect of persistence  
in various internal organs and its lethality. Regulation of virulence using in vitro method 
includes infection of cultured chicken cells to study attachment, invasion and to study the 
effect of lipopolysaccharide as a measure of virulence.  
 
1.2.2. Uropathogenic Escherichia coli 
In our laboratory, it has been shown that BarA-UvrY TCS regulates virulence in 
murine model. To demonstrate chicken embryo lethality assay as an alternative for this 
live murine model and to look at the persistence, embryo lethality in infected SPF eggs 
were determined. Cultured human cells were infected with bacterial cultures to determine 
attachment, invasion and cytotoxic effects. Additionally the secreted protein profiles, 
LPS profile of bacterial cultures were determined and how this LPS and bacterial cultures 




Materials and methods 
2.1. Strains and plasmids 
 The bacterial strains, mutant strains and plasmids for complementation of 
mutation are listed in Table 1. The isogenic barA, uvrY and luxS mutants of APEC 
078:K80:H9 strain χ7122 and UPEC strain CFT073 were constructed using λ Red 
recombination method as described previously (77). 
 
2.2. Determination of bacterial virulence by chicken embryo lethality assay 
To determine the lethality of the E. coli strains, a set of fifteen12-day-old 
embryonated eggs were inoculated with 0.1 ml of 5 x 103 colony forming unit (CFU) of 
bacteria into the allantoic cavity as described previously by Herren CD et al. (42). 
Bacterial cultures were grown under static condition in LB broth at 37ºC for 48 h for two 
passages to induce type 1 and P type pilus. Cells were washed with phosphate buffered 
saline (PBS) and then re-suspended in PBS. Bacterial suspensions containing given 
number of bacteria in 0.1 ml was inoculated into the allantoic cavity by using an 18-
gauge needle. The holes were resealed with glue and the eggs were incubated at 37ºC in 
humidified incubator. Candling of embryos was done every 12 h to monitor the viability. 
Embryos were marked as alive or dead depending upon the integrity of the venous system 







Table 1. E. coli strains and plasmids used in this study 
 
Bacterial Strain or 
plasmid Relevant Genotype Reference or source 
E. coli strains   
DH5α 
luxS supE44 ∆(ф80∆lacZ M15) hsdR17 recA1 endA1 gyrA96 thi-1 
relA1 Invitrogen 
χ7122 APEC O78:K80:H9 gyrA; Nalr R. Curtiss III (43)  
SM3000 χ7122 barA::kan Laboratory collection 
SM3001 χ7122 uvrY::cm Laboratory collection 
SM3003 SM3000 carrying pSM1, Ampr Laboratory collection 
SM3004 SM3001 carrying pSM2; Ampr Laboratory collection 
SM3005 χ7122 luxS::cm Laboratory collection 
SM3006 SM3005 carrying pSM3, Ampr Laboratory collection 
E. coli CFT073  Wild type H. L. Mobley (44) 
SM3007 CFT073 luxS::cm Laboratory collection 
SM3008 SM3007 carrying pSM4, Ampr Laboratory collection 
SM3009 CFT073 barA::cm Laboratory collection 
SM3010 CFT073 uvrY::cm  Laboratory collection 
SM3011 CFT073 csrA::cm Laboratory collection 
SM3012 SM3009 carrying pSM5, Ampr Laboratory collection 
SM3013 SM3010 carrying pSM6, Ampr Laboratory collection 
SM3014 SM3011 carrying pSM7, Ampr Laboratory collection 
E. coli CFT073 CFT073 hlyD::kan Laboratory collection 
E. coli CFT073 CFT073 hlyD::kan carrying pSF4000 containing hlyD; Cmr Laboratory collection 
 
  
   
Plasmids    
pBR322 cloning vector, Ampr Invitrogen 
pSM1 barA gene within pBR322, Ampr Laboratory collection 
pSM2 uvrY gene within pBR322, Ampr Laboratory collection 
pSM3 luxS gene within pCR2.1, Ampr Laboratory collection 
pSM4 luxS gene within pBR322, Ampr Laboratory collection 
pSM5 barA gene within pBR322, Ampr Laboratory collection 
pSM6 uvrY gene within pBR322, Ampr Laboratory collection 













2.3. Chicken embryo lethality assay  
Chicken embryo lethality assay (CELA) was performed in 12-day-old 
embryonated eggs as described previously (45). The persistence of the inoculated 
bacterial cultures in the infected embryos was determined by counting the number of 
bacteria in the various internal organs. Eight 12-day-old embryonated eggs were 
inoculated with 0.1 ml of 5 x 103 CFU of bacterial cultures in PBS. At 24 and 48 h post 
inoculation, viability of the embryos were monitored and recorded. At a given period of 
time, the dead embryos were chosen for dissection. Various internal organs and fluids 
were collected aseptically. All the samples were weighed, homogenized, and centrifuged 
in 2 ml microcentrifuge tubes at 1000 x g for 5 min at room temperature. Bacterial load 
was then determined by plating three serial dilutions of the supernatant in PBS on to LB 
plates with appropriate antibiotics and incubated at 37ºC for 24 h. Bacterial load was 
determined in log 10 CFU/ml (fluids) or per mg (tissues or organs) ± standard deviation 
from four embryos.  
 
2.4. Attachment and invasion assays 
Chicken embryo fibroblast cells (DF1), human ureter (SV-HUC1) and urinary 
bladder (HTB-9) uroepithelial cells were obtained from Dr. Siba K. Samal (Virginia 
Maryland Regional College of Veterinary Medicine (VMRCVM, MD). The cells were 
cultured according to protocol given by ATCC (Manassas, VA). The chicken embryo 
fibroblast cells (DF1) were grown in Dulbecco’s modified Eagle’s medium (DMEM) 




(Gibco Invitrogen).  The human ureter (SV-HUC1) epithelial cells were grown in Ham’s  
F12K medium (Gibco Invitrogen) supplemented with 10% FBS. The human urinary 
bladder (HTB-9) cells were grown in RPMI 1640 medium (ATCC) supplemented with 
10% FBS. All cell lines were grown at 37°C with 5% CO2 incubation. Infection assays 
were performed in ~ 70% confluence monolayer by growing cells in 6-well tissue culture 
plates at 37ºC for 2 days. Type 1 pilus formation was induced by growing bacteria in LB 
media under static condition for 48 h for two passages. P type pilus was induced by 
growing bacteria on 10 tryptic soya agar plates. The experiments were performed with 
both bacterial cultures and similar results were observed. DF1 cells were infected with 
APEC strains and SV-HUC1, HTB-9 cells were infected with CFT073 strains. Adherence 
assays were performed as described previously (46).  
Cultured cells were infected with bacterial suspension with a bacterium: cultured 
cell ratio of 10:1. Just before the start of infection, medium was removed and fresh 
medium was added. Tissue culture plates were centrifuged 600 x g for 5 min and then 
incubated at 37ºC for 2 h. After 2 h, 20 μl of 5% Triton X-100 was used to lyse triplicate 
wells and then plated onto LB agar plates to count the bacterial load (both intra- and 
extracellular bacteria).  Adherent bacteria was calculated from new set of wells washed 
with PBS for five times, lysed in 1 ml of 0.1% Triton X-100, and plated onto LB agar 
plates.  
 To calculate invasion frequencies, a set of wells with adherent cells were washed 
with PBS for five times and bactericidal antibiotic gentamicin (100 μg/ml), which does 




adhered extracellular bacteria and incubated for another 4 h. At the end of incubation, the 
wells were washed with PBS, lysed with 1 ml of 0.1% Triton X-100, and bacterial load 
was calculated by plating onto LB agar plates with appropriate antibiotics.  
 Attachment index was determined as CFU/ml for only adherent bacteria divided 
by total bacterial inoculum (CFU/ml). Invasion index is determined as number of bacteria 
surviving gentamicin incubation divided by the total number of bacteria present before 
gentamicin incubation.  
 
2.5. Chicken macrophage HD11 engulfment and survivability assay 
 Chicken HD11 macrophage cells (a gift from Dr. Siba K. Samal, VMRCVM, 
MD) were cultured according to the protocol given by ATCC. The HD-11 cells were 
grown in RPMI 1640 medium supplemented with 10% FBS. HD11 cells were grown in 
six-well tissue culture plates at a volume of 3 ml of media at 37ºC in 5% CO2. The APEC 
bacterial cultures were grown and infectivity assays were performed as above described.  
To determine the invasion frequencies, after 2 h initial incubation, an additional 
set of wells was washed with PBS, and gentamicin (100 μg/ml) was added to wells and 
further incubated for additional 6 h before enumerating internalized bacteria. Only 
adherent bacteria were calculated using the formula: log10 CFU/ml of attached and 
invaded cells – log10 CFU/ml of invaded cells surviving gentamicin treatment.  
Attachment index was calculated using the formula: CFU/ml of only adherent 




 using the formula: CFU/ml of bacteria surviving gentamicin treatment divided by 
CFU/ml of only adherent bacteria.  
 
2.6. Cytotoxicity assay on cultured human kidney cells 
 
 The human kidney (HK2) cells were obtained from ATCC and cultured 
essentially as described by ATCC. The HK2 cells were grown in Keratinocyte-Serum 
free medium (Gibco Invitrogen) supplemented with 5 ng/ml recombinant epidermal 
growth factor (Gibco Invitrogen) and 0.05 mg/ml bovine pituitary extract (Gibco 
Invitrogen). The HK2 cells were grown in 96-well plate and infection assays were 
performed on ~ 70% monolayer. The HK2 cells were infected with 50 μl of filter 
sterilized culture supernatants from equal number of bacterial cells grown in LB media 
under static condition at 37ºC for 48 h for two passages with appropriate antibiotics. The 
cell proliferation WST-1 assay measures the metabolic activity of viable cells. The viable 
cells convert tetrazolium WST-1 reagent to a water soluble formazan dye (Roche, USA). 
Cytotoxic effects were analyzed as described by the cell proliferation tetrazolium 
colorimetric WST-1 assay system (Roche, USA) and the absorbance of water soluble 
formazan dye was read at 450 nm. The timing of the assay was closely evaluated 
following a cell proliferation WST-1 assay. After treating the cells with bacterial 
supernatants for 3 h, 10 μl of WST-1 reagent was added to each well and the cells were 
incubated for further 180 min at 37ºC.  Absorbance was read at 450 nm using a 






2.7. Calculation of generation time in artificial urine medium 
Simple artificial urine medium was prepared as described previously (47). The pH 
of the artificial urine medium was adjusted to 6.5 and filter sterilized. The generation 
time was calculated when the bacterial cells were growing exponentially in the artificial 
urine medium as per the protocol described by Todar’s Online Textbook of Bacteriology 
http://textbookofbacteriology.net/growth.html (48). 
 
2.8. Hemolysin assay 
 Hemolysis assay with sheep erythrocytes was performed as described before (49, 
50) with slight modifications. The experiments were performed with cells growing in LB 
medium and artificial urine medium. Supernatants of bacterial cultures harvested at an 
optical density (O.D 600) of 0.5 were filtered and taken in 2 ml eppendorf vial. Sheep 
erythrocytes (RBC) were washed and resuspended to 2% (wt/vol) in PBS, 100 μl was 
added to the eppendorf vial, centrifuge the vials at 8000 rpm for 5 min and incubated at 
30.5ºC for 7 h.  Unlysed cells were pelleted and absorbance of the supernatant was 
measured at 405 nm.  
 
2.9. Preparation of secreted protein 
  Secreted supernatant proteins were prepared as described previously (51). 
Bacterial cells were pelleted by centrifugation and supernatant was filtered using 0.2-μm-
pore-size filter. Proteins were precipitated with trichloroacetic acid (25% wt/vol final  




Tris-Glycine gel (Invitrogen Corp., Carlsbad, CA). The gel was stained with Coomassie 
blue and bands of the interest were excised and subjected to mass spectrometry analysis. 
 
2.10. Lipopolysaccharide  
Lipopolysaccharide (LPS) extraction was done by a modified phenol-chloroform 
method using LPS Extraction Kit (Intron Biotechnology, Boca Raton, FL). Bacterial 
cultures were grown under static condition in Tryptic soya broth at 37ºC for 48 h and 
equal number of cells, as enumerated by colony counts upon plating serial dilution of 
cultures, was taken for LPS extraction. Cells were centrifuged at 13,000 rpm for 10 min 
for harvesting. One ml of lysis buffer was added and vortexed vigorously. The 200 μl of 
chloroform was added, vortexed vigorously for 20 seconds, and incubated at room 
temperature (RT) for 5 min. Eppendorf vials were centrifuged at 13,000 rpm for 10 min 
at 4ºC. The 400 μl of supernatant was transferred to a new 1.5 ml tube and 800 μl of 
purification buffer was added and mixed well. Vials were incubated for 10 min at -20ºC 
and centrifuged at 13,000 rpm for 15 min at 4ºC. The LPS pellet was washed with 1 ml 
of 70% ethanol and air dried completely. Finally, LPS was dissolved by boiling in 70 μl 
of ddH20 for 1 min. LPS was separated in SDS-PAGE gel as described previously (52). 
The PAGE gel was stained with silver staining as described by FastsilverTM (G 
Biosciences, St. Louis, MO). During the fixation procedure, 0.7 g of periodic acid was 
added to 100 ml of fixing solution to oxidize the carbohydrate. The pictures were taken 
using Kodak EDAS 290 camera. Using densitometry assay, the concentration of LPS was 




2.11. Cytokine assay 
 
SV-HUC1 uroepithelial cells were grown to confluence in 6 well plates.  The cells 
were treated with equal amount of purified LPS and incubated for 16 h at 37ºC or with 
whole bacterial cells with multiplicity of infection of 10:1 for 4 h at 37ºC. The bacterial 
cells were grown in LB media under static condition for 48 h at 37ºC with appropriate 
antibiotics. The total RNA was isolated from the tissue culture plates using the TRIzol 
reagent (Invitrogen, Carlsbad, CA). The RNA was treated with TURBO DNase (Ambion, 
Austin, TX) and purified using Qiagen RNeasy mini columns (Qiagen, Valencia, CA). 
For quantitative real-time PCR, first strand cDNA was synthesized from 5 μg of total 
RNA using Superscript II (Invitrogen, Carlsbad, CA) and 50 ng of random hexamers 
(Invitrogen, Carlsbad, CA). Internal gene-specific gene primers were used to amplify 
human TNFα (OSM 375 and OSM 376), IL6 (OSM 373 and OSM 374), IL8 (OSM 411 
and OSM 412), GAPDH (OSM 377 and OSM 378) (Table 2).  For real-time PCR, the 
first 10 ng of first-strand cDNA was amplified separately with 10 μM each of gene-
specific primer and GAPDH specific primers (OSM 377 and OSM378) in a 25-μl total 
volume of SYBR green 1 PCR master mix using a PTC-200 Opticon Cycler (Biorad, 
Hercules, CA). The ∆CT values between samples were normalized to those for the 
GAPDH product, as ∆CT  = [CT of uninfected Cytokine (eg. Mock TNFα) - CT of infected 
Cytokine (eg. Infected TNFα)] – [CT of uninfected GAPDH (mock) – CT of infected 
GAPDH]. Because PCR products double with each amplification cycle, the fold 







Table 2. Primers used in this study 
 
 
                                Primers                                 Sequence 
TNF-α amplification primers                                 
OSM 375…………………………………………… 5’-AGGCAGTCAGATCATCTTCTCG-3’ 
OSM 376…………………………………………… 5’-CCTTGAAGAGGACCTGGGAGTA-3’ 
 
IL-6 amplification primers 
OSM 373………………………………………….... 5’-TTCGGTCCAGTTGCCTTCTC-3’  
OSM 374…………………………………………… 5’-GTTTTCTGCCAGTGCCTCTTT-3’ 
 
IL-8 amplification primers 
OSM 411…………………………………………… 5’-CTCTTGGCAGCCTTCCTGA-3’  
OSM 412…………………………………………… 5’-CCTCTGCACCCAGTTTTCCT-3’ 
 
GAPDH amplification primers 
OSM 377…………………………………………… 5’-TGGTCTCCTCTGACTTCAACAG-3’ 














Results and Discussion 
 
3.1.  Avian pathogenic E. coli 
3.1.1. Role of BarA-UvrY TCS in determining virulence in E. coli O78:K80:H9 
(χ7122) 
3.1.1.1. The barA and uvrY mutants poorly colonize embryonic tissues and fail to 
persist within the liver and spleen 
To investigate the virulence of  barA or uvrY mutant, eight 12-day-old embryos 
were infected with various strains. At 24 h and 48 h, a set of four embryos was harvested, 
and the bacterial load was determined in various tissues (Table 3). Although barA 
mutants were able to colonize the chorioallantoic membrane (CAM) and the liver ( 3.0 ± 
1.4 log10 CFU/mg of tissue), multiply in allantoic fluid (ALF) and amniotic fluid ( 2.0 ± 
1.0 log10 CFU/ml of fluid), they were unable to persist in the lungs or spleen. The 
persistence in liver and lungs decreased about10-fold after 48 h of infection. The uvrY 
mutant could initially replicate in ALF and colonize CAM, liver, and lungs, but it failed 
to persist in these organs, particularly in the liver ( 200-fold decrease) after 48 h of 
incubation. However, complementation of the uvrY mutant strain by a plasmid-borne 
copy of the wild-type uvrY gene (p-uvrY) (pSM2) restored colonization and persistence. 
These results, particularly the number of bacteria in the liver and spleen, indicate that 
UvrY may regulate virulence determinants required for systemic infection in the chicken 
embryo. Since the initial site of APEC infection is the lungs (air sacculitis), followed by a 




nonfunctional BarA-UvrY TCS may lead to poor colonization of the lung tissues and 
limit systemic invasion. Interestingly, unlike wild-type strains, embryos infected with 
mutants did not exhibit pericardial lesions, a characteristic of cellulitis-derived isolates 
(53). Our results show the abilities of APEC strain χ7122 to colonize in lungs, invade the 
internal organs, and disseminate in allantoic and amniotic fluids of a 12-day-old embryos 
are essentially similar to that shown for the same APEC strain in 3.5-week-old chickens 
by Mellata et al. (54). Our results, therefore, suggest that 12-day-old SPF chicken 


















Table 3. Attributes of APEC strain χ7122 and various isogenic mutants to colonize 12-
day-old chicken embryos, invade internal organs, and disseminate in allantoic and 
amniotic fluids after 24 h and 48 h of infections 
Tissue infectivity 
Strain Genotype 
log10(CFU/ml or mg of tissue) at the  
following time after infection. 
   Tissue 24h 48h 
χ7122 Wt CAM 2.2 ± 1.2 3.1 ± 1.5 
   ALF 2.0 ± 1.2 3.4 ± 1.0 
   AMF 2.2 ± 1.2 3.1 ± 1.6 
   Liver 3.8 ± 1.9 3.9 ± 1.2 
   Spleen 2.0 ± 1.9 3.2 ± 1.8 
   Lungs 3.3 ± 1.9 3.8 ± 1.8 
      
SM3000 barA CAM 2.1 ± 1.9 3.2 ± 1.5 
   ALF 2.0 ± 0.7 2.0 ± 1.3 
   AMF 2.0 ± 1.0 2.1 ± 1.5
a,b 
   Liver 3.1 ± 1.4
a,b 2.1 ± 1.0 
   Spleen <1 ± 0.1
a,b <1 ± 0.1a,b 
   Lungs 1.8 ± 0.8
a,b <1 ± 0.1a,b 
      
SM3001 uvrY CAM 2.2 ± 1.2 <1 ± 0.1a,b 
   ALF 1.8 ± 1.0a,b <1 ± 0.1a,b 
   AMF <1 ± 0.1
a,b <1 ± 0.1a,b 
   Liver 3.3 ± 1.4
a,b 1.5 ± 1.2a,b 
   Spleen <1 ± 0.1
a,b <1 ± 0.1a,b 
   Lungs 2.1 ± 1.3
a,b <1 ± 0.1a,b 
      
SM3004 uvrY/p-uvrY CAM 2.7 ± 0.9 3.2 ± 1.3 
   ALF 2.1 ± 1.3 2.0 ± 0.9 
   AMF 3.6 ± 1.4 3.5 ± 1.0 
   Liver 3.5 ± 1.4 3.6 ± 1.5 
   Spleen 3.2 ± 1.4 3.5 ± 1.5 
   Lungs 3.2 ± 1.3 3.5 ± 1.5 
          
 























3.1.1.2. Mutation in barA or uvrY reduces adherence and invasion to cultured 
chicken embryo fibroblasts 
To further investigate the decreased embryo lethality in mutant strains of χ7122, 
we assayed for the possibility of barA and uvrY might have effects on the initial 
attachment of bacteria to a cultured chicken embryo fibroblast line, DF-1 (55). For APEC 
to cause colibacillosis, bacterial cells must be able to invade epithelial cells and move 
through the host fibroblasts that make up the connective tissue. In vivo, the uvrY mutant 
colonized the chorioallantoic membrane, an epithelium, 100-fold more poorly than the 
wild-type strain did (Table 3). Since we did not have a transformed chicken epithelial cell 
line, we assayed the abilities of barA and uvrY mutant strains and uvrY-complemented 
strain of APEC to adhere to and invade chicken fibroblasts (Table 4). Deletion of either 
the barA or uvrY gene in strain χ7122 reduced bacterial attachment to fibroblasts by 100-
fold ( 2 log10 CFU/ml difference) in comparison with wild type (Table 4). These low 
adherent phenotypes could be complemented to wild-type χ7122 levels when the 
respective gene was provided in trans. Complementation was best achieved in the uvrY/p-
uvrY complemented strain (Table 4 and Figure 1A to D). About 16% of the adherent 
APEC could invade DF-1 cells, as indicated by their ability to resist gentamicin treatment 
after 6 h of initial infection (Table 4). However, a mutation in either barA or uvrY 
(especially uvrY), led to almost 100-fold reduction in invasiveness of these mutants that 
were adhering to DF-1 cells. The invasiveness could be restored to near wild-type levels 




either directly or indirectly, regulates a number of bacterial determinants responsible for 
attachment and invasion of APEC strains. The BarA-SirA TCS has been shown to be 
required for full virulence in S. enterica because of its effects on the type III secretion 
system (28, 26). This TCS has also been implicated in regulating invasiveness in 



























Initial cellsa        


















wild type 8.6 ± 0.9 7.1 ± 0.9 6.4 ± 0.8 7.1 ± 0.9 2.7 x 10–2 2.0 x 10–1 
barA 8.6 ± 0.9 6.7 ± 0.8 4.8 ± 0.7 6.6 ± 0.8 1.2 x 10–2 1.5 x 10–2 
uvrY 8.6 ± 0.9 6.3 ± 0.8 4.0 ± 0.6 6.3 ± 0.8 5.0 x 10–3 5.0 x 10–3 
uvrY/p-uvrY 8.6 ± 0.9 7.2 ± 0.9 6.3 ± 0.8 7.1 ± 0.8 4.5 x 10–2 1.3 x 10–2 
 
  
Figure 1. Mutation in uvrY reduces the attachment to cultured chicken fibroblasts and macrophages 
 
     Figure 1. The monolayers of cultured cells over glass coverslips were incubated with bacteria with a multiplicity of infection of 10. 




BH-2 microscope with a 100x objective lens. Attachment of E. coli 7122 (wild type [wt]), uvrY mutant, and uvrY mutant 
complemented with a plasmid-borne copy of the wild-type uvrY gene (p-uvrY). (A to D), Attachment to DF-1 chicken fibroblasts. 
Arrows indicate surface-attached bacteria. (E to H), Attachment to HD11 chicken macrophages. Panels F and H show attached 












3.1.1.3. Mutation in barA or uvrY reduces survival within chicken macrophage  
The most common form of APEC infection in poultry is characterized by initial 
respiratory tract colonization followed by a systemic spread to other parts of the body. 
Avian air sacs do not have cellular defense mechanisms and depend initially on the influx 
of heterophils followed by macrophages as a cellular defense (56, 57). APEC strains are 
known to be associated in vivo with macrophages of the air sacs and lungs, while 
nonpathogenic strains were observed to lack these attributes (56). Moreover, the 
pathogenic APEC strains are more resistant to killing by chicken macrophages in vitro 
than the low-pathogenic strains (54, 58). Therefore, using HD-11 chicken macrophage 
line, we examined the effects of mutations of barA and uvrY on bacterial survival within 
cultured macrophages. Internalized fractions of bacteria surviving within HD-11 
macrophages were enumerated by the standard gentamicin protection assay (46). There 
appeared to be no differences in adhesion (Table 5). However, mutation in barA reduced 
APEC survival within chicken macrophages by 1,000-fold compared to that of the wild 
type, and the uvrY mutant survived but at a level 104-fold less than that of the wild type 
(Table 5). Although there was adherence defect, the difference in survival of internalized 
bacteria, compared to wild type, is significant (P < 0.05). The mutant bacteria appeared to 
be engulfed quickly by the macrophages, while the wild-type or uvrY/p-uvrY 





















Initial cellsa        


















wild type 8.4 ± 0.9 7.0 ± 0.8 5.1 ± 0.7 7.0 ± 0.7 4.5 x 10–2 1.3 x 10–2 
barA 8.9 ± 0.9 7.0 ± 0.8 3.8 ± 0.6 7.0 ± 0.7 1.4 x 10–2 7.0 x 10–4 
uvrY 8.9 ± 0.9 7.0 ± 0.8 3.4 ± 0.5 7.0 ± 0.5 1.4 x 10–2 7.0 x 10–4 
uvrY/p-uvrY 8.7 ± 0.9 7.1 ± 0.8 5.3 ± 0.7 7.1 ± 0.6 2.2 x 10–2 1.7 x 10–2 
 
  
3.1.2. Role of LuxS in determining virulence in E. coli O78:K80:H9 (χ7122) 
3.1.2.1. The mutation in LuxS reduces virulence of E. coli O78:K80:H9 (χ7122) in 
vivo 
The virulence of the bacterial strain E. coli O78:K80:H9 (χ7122) was determined 
using chicken embryo lethality assay by the number of embryos killed within a given 
period of time (Figure 2). A mutation in the luxS gene reduced virulence by 47% (7 out of 
15), embryos were dead after 53 h post inoculation compared to all embryos dead under 
similar conditions infected with wild-type strain (Figure 2). The reduction in virulence 
was significant (P < 0.05). Complementation of luxS in plasmid increased the virulence 
by 26% to 73% (Figure 2). The complementation did not restore the virulence to that of 
wild type, indicating that other factors contribute to the overall virulence. Since the luxS 
mutation revealed only partial reduction in virulence in chicken embryo lethality assay, 
we performed the complementation assay. The complementation of luxS in plasmid could 
not able to restore the virulence as that of wild type. The loss of plasmid from the embryo 
due to the absence of antibiotic selection may be contributed to this effect in vivo. 
However, the reduction in virulence is not similar to that of avirulent strain E. coli K-12, 
indicating that virulence determinants are multifactorial in nature and LuxS is one of the 


























The lethality was determined by inoculating 0.1 ml of 5 x 103 CFU of  bacteria into the 
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3.1.2.2. The luxS mutant poorly colonizes in embryonic tissues and fails to persist 
within the liver and spleen 
Wild type bacteria χ7122 was able to invade and persist well in internal organs 
and fluids as tested (Table 6). There was no reduction in the bacterial load by 48 h in wild 
type bacteria. The infection with mutant luxS bacteria showed no significant difference at 
24 hr post inoculation (Table 6). However, by 48 h, there was a significant reduction in 
the bacterial load in amniotic fluid, liver, lung and spleen (~ 200 fold or more) when 
compared to that of wild type (Table 6). The reduction in bacterial load in the internal 
organs and fluids can be restored by complementation in plasmid to that of wild type. 
Mutation in luxS had resulted in partial reduction in virulence, which is similar to 
previous studies reported by Sperandio et al., 1999 (36), Stroeher et al., 2003 (59) and 
Sircili et al., 2004 (37). The persistence of the mutant bacteria in the internal organ was 
reduced. Poor colonization of the internal organs, like lung and spleen may limit the 
systemic spread and reduce generalized infections. Determination of the virulence by 
enumerating the persistence of bacteria in the internal organs in 12-day-old SPF chicken 










Table 6. Attributes of APEC strain χ7122 and isogenic mutant to colonize in12-day-old 
chicken embryos, invade the internal organs, and disseminate in allantoic and amniotic 
















a This value is significantly different (P < 0.05) from the value for the wild-type strain.  




Strain Genotype log10(CFU/ml or mg of tissue) at the  
following time after infection 
   Tissue 24h 48h 
χ7122 Wt CAM 2.2 ±  1.2 3.1 ±  1.5 
   ALF 2.0 ±  1.2 3.4 ±  1.0 
   AMF 2.2 ±  1.2 3.1 ±  1.6 
   Liver 3.8 ±  1.9 3.9 ±  1.2 
   Spleen 2.0 ±  1.9 3.2 ±  1.8 
   Lungs 3.3 ±  1.9 3.8 ±  1.8 
      
SM3005 luxS- CAM 2.7 ± 1.2 3.2 ± 0.1 
   ALF 2.1 ± 1.0  3.0 ± 0.1 
   AMF 3.6 ± 0.1  <1 ± 0.1a,b 
   Liver 3.5 ± 1.4  1.5 ± 1.2 
   Spleen 3.2 ± 0.1  <1 ± 0.1a,b 
   Lungs 3.2 ± 1.3  <1 ± 0.1a,b 
      
SM3006 luxS-/ p-luxS- CAM 2.0 ± 0.9 3.2± 1.2 
   ALF 2.1 ± 1.0 2.0 ± 0.8 
   AMF 3.0 ± 1.2 3.5 ± 1.2 
   Liver 3.6 ± 1.2 3.6 ± 1.2 
   Spleen 3.0 ± 1.0 3.5 ± 1.4 
    Lungs 3.0 ± 1.2 3.5 ± 1.5 
 
  
3.1.2.3. Mutation in luxS reduces invasion to cultured chicken embryo fibroblasts 
Attachment and invasion abilities of the luxS mutant strain to the cultured chicken 
embryo fibroblasts cells were analyzed (Table 7). There was no significant difference in 
the attachment of the bacterial cells to the cultured chicken fibroblast cells. However, 
there was a 10-fold reduction in the invasiveness of the luxS mutant strains when 
compared to that of wild type. Complementation of luxS gene in trans restored the 
invasiveness to that of wild type (Table 7). The systemic infection of the bacteria is 
dependant on its ability to attach and invade the epithelial cells and invade through 
fibroblast cells.  The invasiveness of the mutant luxS bacteria was reduced by 10-fold in 
the cultured chicken embryo fibroblast and this attributed to the decreased embryo 
lethality and persistence of the mutant bacteria in the internal organs.  The adherence of 
luxS mutant bacteria of EPEC had two-fold reduction on cultured HeLa epithelial cells 














Table 7. Mutation in luxS reduces invasion of E. coli O78:K80:H9 strain χ7122 to chicken embryo fibroblast cells 
 









Initial cellsa          
(log10 CFU / ml) 
Attached and 
invaded after 2h a 
(log10 CFU / ml) 
Invaded fraction 
surviving after 4h a 
(log 10 CFU / ml) 
Calculated attached 






wild type 8.6 ± 0.9  7.0 ± 0.8  6.3 ± 0.8 6.9 ± 0.8 2.0 x 10-2 2.2 x 10-1 
luxS 8.6 ± 0.9 6.7 ± 0.8  5.0 ± 0.7 6.7 ± 0.8 1.5 x 10-2 1.5 x 10-2 
luxS/p-luxS 8.6 ± 0.9 6.9 ± 0.8 6.0 ±  0.8 6.8 ± 0.8 1.7 x 10-2 1.6 x 10-1 
 
  
3.1.2.4. Mutation in luxS reduces survival within chicken macrophage 
 The effects of luxS mutation on survival within cultured macrophage were 
enumerated by standard gentamicin protection assay (Table 8).  There was no significant 
difference in the adherence. However, luxS mutation reduced APEC survival by 10-fold 
when compared to that of wild type within the macrophages (Table 8). Complementation 
of luxS in plasmid restored the survivability to that of wild type. APEC colonizing air 
sacs resulted in respiratory tract infections like air sacculitis, followed by systemic spread 
to the other parts of the body. Innate immune defense mechanism within air sacs included 
migration of heterophils as first line of defense, followed by macrophages ( 60, 57).  The 
survivability within macrophages depends on the virulence factors of the bacteria to 
withstand the macrophage killing. The less pathogenic bacteria are more susceptible to 
killing by chicken macrophages than the pathogenic strains  (58). The luxS mutant 
bacteria was survived 10-fold lesser within the cultured chicken macrophage HD11 cells 






























Initial cellsa         
(log10 CFU / 
ml) 
Attached and 
invaded cells after 
2h a (log10 CFU/ml) 
Invaded fraction 




(log 10CFU/ml)  
Attachment 
index  Survival Index  
wild type 8.5 ±  0.9  7.1 ± 0.9 5.3 ±  0.7 7.1 ± 0.9 3.8 x 10 -2 1.5 x 10 -2 
luxS 8.7 ±  0.9 7.1 ± 0.9 4.2 ±  0.6 7.1 ± 0.9 2.9 x 10-2  1.2 x 10-3 
luxS/p-luxS 8.7 ±  0.9 7.0 ± 0.8 5.1 ±  0.7 7.0 ± 0.8 2.0 x 10-2  1.4 x 10-2  
 
  
3.1.2.5. Mutation in luxS alters the lipopolysaccharide profile 
Survival from macrophage engulfment or thereafter is attributed to carbohydrates 
of the outer membrane and is often correlated to LPS. To see whether there was any 
defect in overall LPS production, LPS was isolated from equal number of cells and 
resolved in 12 % SDS-PAGE as shown in Figure 3. The LPS profile of the luxS mutant 
exhibited visible differences in the core and O-antigen compared to that of wild type. In 
the mutant luxS, there was a difference in both mobility and quantity of the LPS 
compared to the wild type. Some bands of the O-antigen were missing and few other 
bands were less prominent when compared to χ7122 wt LPS (Figure 3). Quantification of 
the LPS with densitometry was done by comparing with standard E. coli LPS (Sigma, St. 
Louis, MO). We found that from a given number of E. coli cells (4 x 109), there was ~ 2-
fold reduction in LPS of the luxS mutant strain (671 ng/μl) as compared to the wild type 
(1705 ng/μl). This indicates that the reduced virulence properties can be partially 
attributed to the over all production of LPS. The change in mobility of the LPS bands 
also indicates that there is probably change in LPS structure.  Therefore, the reduction in 
virulence is due to the defect in the lipopolysaccharide profile of the bacteria. LPS is a 
potent endotoxin responsible for gram negative septicemia (61). Additionally, LPS is 
responsible for the production of variety of proinflammatory cytokines followed by septic 
shock and disseminated intravascular coagulation of the infected animals (62). Wild-type 
bacteria had fully functional LPS responsible for cytotoxic and anti-phagocytic effects in 
chicken embryo model and increased invasion and survivability in cultured chicken cells, 




Moreover, from equal number of bacterial cells, wild-type bacteria had more 
concentration of LPS in comparison to that of mutant bacteria. This study suggests that 
a disruption of the methyl cycle, ie., recycling methionine, leads to a defect in the 
assembly and transport of LPS. This is probably one of the factors modulating the 





















Figure 3. Detection of equal amount of lipopolysaccharide patterns by silver stain 





















Figure 3. LPS extracted from equal number of cells.  LPS resolved in 12% SDS-PAGE 
gel and stained with silver stain. The upper bands represent the O antigen and the lower 








3.2. Uropathogenic E. coli 
3.2.1. Role of BarA-UvrY TCS in determining virulence in E. coli CFT073 
3.2.1.1. Mutation in uvrY reduces lethality in chicken embryo lethality assay 
The mouse UTI assays showed that mutation in uvrY reduces the virulence than 
that of wild type (Dr. Suman Mukhopadhyay, personal communication). We looked for 
viable alternative for testing virulence using mouse UTI. The virulence of BarA-UvrY 
TCS of avian pathogenic E. coli strain χ7122 was shown using chicken embryo lethality 
assay (42). Here we demonstrated that the chicken embryo lethality assay could also be 
used to determine the virulence of these strains and had similar effects to that observed in 
vivo mouse UTI model. The virulence was determined using chicken embryo lethality 
assay by the number of embryos killed within a given period of time. By 72 h post 
inoculation, all the embryos infected with wild type strain were dead (100%), whereas 
mutation in barA and uvrY  genes decreased the virulence by 67% (8 out of 12 embryos 
were dead), and 58% (7 out of 12 embryos were dead) up to 6 days post inoculation 
respectively. The reduction in virulence was significant (P<0.01) (Figure 4). These 
virulence could be restored to wild type CFT073 when the respective genes was provided 
in trans. Complementation was 100% in barA/p-barA strain and 91% (11 out of 12 
embryos dead) in uvrY/p-uvrY strain. Deletion of csrA in strain CFT073 increased the 
virulence to 75% (9 out of 12 embryos dead). The virulence was decreased to 50% (6 out 
of 12 embryos dead) in the csrA/p-csrA strain (Figure 4).  Mutation in hlyD (hemolysin 
gene) also reduced the virulence to 58% and complementation of hlyD in plasmid 
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■ = CFT073, □ = DH5αΚ12,  ▲ = barA, Δ = barA/p-barA, ● = uvrY  ○ = uvrY/p-uvrY, 
◊ = csrA, х = csrA/p-csrA.  The lethality was determined by inoculating 0.1 ml of 5 x 103 










3.2.1.2. Mutation in uvrY reduces the invasion to cultured ureter uroepithelial cells 
The functional roles of barA and uvrY genes in regulating attachment and 
invasion in cultured uroepithelial cells was investigated by using standard gentamicin 
protection assays (46). Attachment and invasion abilities of mutant barA and uvrY 
bacteria compared to that of wild type were unaltered in cultured urinary bladder (HTB-
9) epithelial cells (Table 10 and Figure 5). Mutation in uvrY reduced the invasion abilities 
by two logs (~ 100-fold) in cultured ureter (SV-HUC1) epithelial cells (Table 9 and 
Figure 5).  The attachment of the bacteria was unaltered and there was no significant 
difference. Expression of uvrY in trans in plasmid pBR322 restored the invasion abilities 
in cultured ureter (SV-HUC1) cells similar to that of wild type. However, deletion of 
barA had no effect on the attachment and invasion in cultured ureter (SV-HUC 1 cells) 
(Table 9). This indicates that as a transcriptional regulator, UvrY protein has a larger role 
in determining virulence and an uvrY mutant is less virulent than a barA mutant. Deletion 
of csrA which controls carbon metabolism, flagellum biosynthesis (29, 24, 30) resulted in 
unaltered invasiveness like that of wild-type, while the csrA/p-csrA complemented strain 



























Initial cellsa    




2ha  (log10 
CFU / ml) 
Invaded fraction 
surviving after 
4ha  (log 10 
CFU / ml) 
Calculated 
attached 






wild type 8.4 ± 0.9 7.4 ± 0.8 3.1 ± 0.5 7.5 ± 0.8 7.7 × 10-2 6.8 × 10-5 
barA 8.3 ± 0.9 7.2 ± 0.9 3.0 ± 0.5 7.2 ± 0.9 8.3 × 10-2 6.6 × 10-5 
barA/p-barA 8.9 ± 0.9 7.7 ± 0.9 3.3 ±  0.5 7.7 ± 0.9 6.3 × 10-2 4.7 × 10-5 
uvrY 8.6 ± 0.9 6.8 ± 0.8 0.7 ±  0.1 6.8 ± 0.8 1.7 × 10-2 7.1 × 10-7 
uvrY/p-uvrY 8.8 ± 0.9 7.6 ± 0.9 2.9 ±  0.5 7.6 ± 0.9 6.3 × 10-2 1.9 × 10-5 
csrA 7.7 ± 0.9 6.6 ± 0.8 2.2 ±  0.3 6.6 ± 0.8 8.9 × 10-2 3.6 × 10-5 
csrA/p-csrA 7.7 ± 0.9 6.6 ± 0.8 0.7 ±  0.1 6.6 ± 0.7 7.8 × 10-2 1.3 × 10-6 
 
  

















Initial cellsa    




2ha  (log10 
CFU / ml) 
Invaded fraction 
surviving after 
4ha  (log 10 
CFU / ml) 
Calculated 
attached 






wild type 8.8 ± 0.9 7.1 ± 0.8  3.6 ± 0.6 7.1 ± 0.8 1.41 × 10-2 4.4 × 10-4 
barA 8.7 ± 0.9 6.7 ± 0.8  3.3 ± 0.5 6.7 ± 0.8 1.02 × 10-2 4.5 × 10-4 
barA/p-barA 8.6 ± 0.9 6.7 ± 0.8 3.3 ±  0.5 6.7 ± 0.8 1.36 × 10-2 3.6 × 10-4 
uvrY 8.7 ± 0.9 6.7 ± 0.8 3.5 ±  0.5 6.7 ± 0.8 1.32 × 10-2 3.9 × 10-4 
uvrY/p-uvrY 8.5 ± 0.9 7.4 ± 0.9 5.5 ±  0.7 7.4 ± 0.9 6.9 × 10-2 1.4 × 10-2 
csrA 7.4 ± 0.9 6.3 ± 0.8 2.9 ±  0.5 6.3 ± 0.8 8.7 × 10-2 3.9 × 10-3 
csrA/p-csrA 7.3 ± 0.9 5.0 ± 0.7 2.2 ±  0.3 5.0 ± 0.7 4.9 × 10-3 1.6 × 10-3 
 
  





















bacteria (grown under static conditions) with a multiplicity of infection of 10. The  
unattached bacteria were washed, stained with Hema-3 stain, and visualized using a Spot 
RT camera attached to an Olympus BH-2 microscope with a 100x objective lens. 
Attachment of E. coli CFT073, uvrY mutant, uvrY mutant complemented with a plasmid-
borne copy of the wild-type uvrY gene (p-uvrY), csrA mutant and csrA mutant 
complemented with a plasmid-borne copy of the wild-type csrA gene (p-csrA). Attached 
bacteria indicated by arrows. (A to F), Attachment to human urinary bladder (HTB-9) 


















3.2.1.3. Mutation in uvrY reduces the cytotoxic effect to cultured human kidney cells 
Mutation in uvrY reduced the cytotoxic effects of the bacterial supernatants on 
cultured human kidney HK-2 cells. The timing of the assay was closely evaluated (data 
not given), and suitable time point for reading the assay was calculated and found to be 
180 min after the addition of WST-1 reagent to the infected cells (Table 11 and Figure 6). 
The growth was inhibited and 21% of the treated cells were alive in wild type, while 
deletion of barA, uvrY and hlyD reduced the cytotoxic effects and 38%, 68% and 35% of 
the cells with relative to the control.  The reduction in the cytotoxicity was significant for 
uvrY (p ≤ 0.001) and barA, hlyD (p ≤ 0.01) mutant bacteria compared to the wild type 
(Table 11). Complementation of the genes in plasmid restored the effects to that of wild 
type. This experiment also demonstrated that uvrY mutant is less virulent than barA 
mutant. However csrA mutant is more cytotoxic compared to wild type as only 13% of 













Figure 6. Mutation in uvrY reduces the cytotoxic effect to cultured human kidney cells 
                                                                 
Figure 6. Phase-contrast photomicrographs of human kidney cells (HK-2 cells) (A), 6 hours after treating cells with supernatants of  
 
  
CFT073 wild type (B), csrA (C), barA (D), uvrY (E) and hlyD (F), barA/p-barA (G), uvrY/p-uvrY (H) and csrA/p-csrA (I). Note the 

















Table 11.  Mutation in uvrY reduces cytotoxic effects on cultured human kidney cells 
Genotype Percentage of survival 
a 
(relative to control) 
Control 100  
CFT073 wild type 21 ± 3 
hlyD 35 ± 2* 
hlyD/p-hlyD 21 ± 2 
barA 38 ± 3* 
barA/p-barA 22 ± 2 
uvrY 68 ±  2** 
uvrY/p-uvrY 22 ± 3 
csrA 13 ±  4 
csrA/p-csrA 36 ± 3 
 
a Data obtained from three independent experiments with 6 replicates per condition. (*, p 
















3.2.1.4. Mutation in uvrY causes growth defect in artificial urine medium 
Mutation in uvrY reduced the virulence in the mouse model, chicken embryo 
lethality assay, cytotoxicity of the HK-2 cells and also reduced the invasion abilities in 
SV-HUC1 cells. Consequently, we examined the virulence factors that are responsible for 
the reduction in the virulence. We tried to identify virulence factors in the bacterial 
culture supernatant, differences in lipopolysaccharide and for growth defects in the 
artificial urine medium. The bacteria causing urinary tract infection has to grow in human 
urine. Urine is a variable fluid and its composition varies between individuals and in the 
same individual over time (63). The composition of the urine varies by fluid intake, 
exercise, ambient temperature and diet. The pH can vary from 4.5 to 8 (64). To avoid the 
variations found in the human urine over time, a simple artificial urine medium having 
mid-point values for each component is used to determine the growth properties of the 
bacteria. The bacteria were grown in filter sterilized artificial urine medium (pH 6.5). 
When compared with the wild type, the generation time of the uvrY, and barA mutant 
bacteria was increased by 62 and 29 min respectively in the exponential phase (Table 12). 
However, all the bacterial strains reached almost the same OD in the stationary phase 
(data not given). Deletion of hlyD and csrA also increased the generation time by 93 and 
54 min, respectively. Complementation of the genes in plasmid restored the generation 
time almost to that of wild type. The growth defect of the mutant bacteria observed 
during the exponential phase may result in the decreased fitness in the urine medium, 





Table 12. Mutation in barA or uvrY increases the generation time during exponential 
phase and decreases hemolysis of sheep erythrocytes in coculture with bacterial culture 
supernatant grown in artificial urine medium 
Genotype Generation time (min)a Hemolysis of sheep erythrocytes (OD 405)a 
CFT073 wild type 102.24 ± 2.31 2.7 ± 0.19 
hlyD 195.6 ± 3.34* 0.57 ± 0.09 
hlyD/p-hlyD 128.32 ± 1.62 10.3 ± 0.28 
barA 135.05 ± 2.15* 0.53 ± 0.12*** 
barA/p-barA 115.16 ± 3.42 1.85 ± 0.10 
uvrY 164.31 ± 3.42* 0.35 ± 0.14*** 
uvrY/p-uvrY 122.48 ± 3.42 3.6 ± 0.18 
csrA 156.53 ± 3.42* 3.9 ± 0.28** 
csrA/p-csrA 125.44 ± 3.42 0.39 ± 0.22*** 
 
aData obtained from mean values ± standard deviations from three different experiments. 















3.2.1.5. Mutation in uvrY alters secreted protein Hemolysin  
 Since the uvrY mutant exhibited decreased virulence in mouse model, chicken 
embryo killing and cytotoxicity to cultured HK-2 cells, we compared the secreted protein 
profile in culture supernatant to identify the virulence determinants of various mutants to 
that of wild type bacteria. The protein profiles of these filtered bacterial culture 
supernatant were identified by resolution via 4-20% Tris-Glycine gradient SDS-PAGE 
gel (Figure 7).  The bands of the interest were excised and subjected to mass 
spectrometric analysis. One band of approximately 110 kDa was found to be Hemolysin 
by protein BLAST analysis. Hemolysin is a cytotoxic protein. Decrease in the hemolytic 
activity of uvrY mutant is correlated with its decreased virulence on cultured HK- cells, 
chicken embryo killing and in mouse UTI. The UPEC bacteria express its virulence 
factors and colonize the bladder, causing cystitis or in kidney resulting in pyelonephritis. 
The exotoxin Hly is one of the virulence factors associated with pathogenesis and the 
production of hemolysin protein contributes to the virulence of extra-intestinal 
pathogenic E. coli infections (65, 49). The BarA-UvrY family of TCSs is known to 
regulate virulence in different bacterial species (24, 31, 32, 42). The 110 kDa hemolysin 
protein (HlyA) (66, 67) was down regulated in the mutant compared to wild type (Figure 
7). We investigated the role of the activity of hemolysin protein obtained from filtered 
bacterial culture supernatant grown in artificial urine medium against sheep erythrocytes 
at 30.5ºC for 7 h. The hemolytic activity of uvrY and barA mutants when compared to 
wild type bacteria was considerably different (p < 0.01). There was more than 5 and 7-




Complementation in plasmid restored the hemolytic activity similar to wild type. The 
decreased exotoxin HlyA activity contributed to the reduction in the virulence of mutant 
bacteria. However deletion of csrA resulted in moderate increase in hemolytic activity 
and it’s complementation in plasmid decreased the hemolytic activity. Thus, it appears 
that hemolysin expression is regulated by BarA-UvrY TCS. The hemolytic activities of 
cultured bacterial supernatant contribute to the reduced cytotoxic effects against cultured 




























kDa 1 72 3 4 5 6 108 9
0.30.1 2.5 0.5 1.8 0.3 3.5 3.9
Amount of heme release /ml 
 
  
Figure 7. Protein samples were separated by 4 to 20% SDS-PAGE and stained with Coomassie blue. Lanes: 1. Protein marker, 2. LB 
media, 3. CFT073 wt, 4. barA, 5. barA/p-barA, 6. uvrY, 7. uvrY/p-uvrY, 8. csrA, 9. csrA/p-csrA, 10. Protein marker.  
MS analysis result. 
Hemolysin A [Escherichia coli CFT073] (indicated by arrow mark 1) 
Score = 40.8 bits (94), Expect = 0.017, Identities = 21/21 (100%), Positives = 21/21 (100%), Gaps = 0/21 (0%)  
Query 1   KNLTETDNLYSVEELIGTTRA 21  
                KNLTETDNLYSVEELIGTTRA  











Table 13. Secreted proteins, analyzed by mass spectrometry, that are differentially 
expressed by the CFT073 strains  
Protein band identification 
number MS protein BLAST analysis 
1 Hemolysin A Escherichia coli CFT073  
2 
Pilin type F7 1 precursor Escherichia coli, major 
pilus subunit 
 




















3.2.1.6. Mutation of either uvrY or csrA alters Lipopolysaccharide profile 
We investigated the role of LPS in pathogenesis. LPS is a potent endotoxin 
responsible for gram negative septicemia (61) and responsible for the production of 
variety of proinflammatory cytokines followed by septic shock and disseminated 
intravascular coagulation of the infected animals (62). LPS was isolated from equal 
number of cells and resolved in 12 % SDS-PAGE as shown in the Figure 8. The LPS 
profile of the uvrY mutant exhibited visible differences in the core and O-antigen 
compared to that of wild type. In the mutant uvrY, there was a difference in both mobility 
of bands and quantity of the LPS compared to the wild type. Some bands of the O-
antigen were missing and few other bands were less prominent when compared to 
CFT073 wt LPS (Figure 8). Complementation restored the effect to wild type. Deletion 
of csrA resulted one high molecular weight O-antigen band became less prominent and 
few low molecular weight O-antigen bands were more prominent. The csrA/p-csrA 
complemented strain reduces the LPS expression. Quantification of the LPS with 
densitometry assay was done by comparing with standard E. coli LPS. We found that 
from a given number of E. coli cells (4 x 109), there was partial reduction in LPS of the 
uvrY mutant strain (723 ng/μl) as compared to the wild type (853 ng/μl). The csrA mutant 
had the highest concentration of LPS (2080 ng/μl) and csrA/p-csrA complemented strain 
leads to reduced expression of LPS (643 ng/μl).  Thus LPS production is probably 
regulated at the post transcription level. This partial reduction in the LPS may also 





Figure 8. Detection of lipopolysaccharide patterns by silver stain 
 
Figure 8. LPS extracted from equal number of cells.  LPS resolved in 12% SDS-PAGE 
gel and stained with silver stain. The upper bands represent the O antigen and the lower 
bands represent the core LPS antigen. Lanes: 1. CFT073 wt, 2. barA, 3. barA/p-barA, 4. 










3.2.1.7. Mutation in uvrY down regulates inflammatory cytokines 
 LPS is an integral part of outer membrane of UPEC. Bacterial infections or LPS 
triggers mucosal cytokine production ( 68, 69, 70). The mucosal cytokines are derived in 
part from epithelial cells. Uroepithelial cells secrete interleukin-6 (IL-6) and IL-8 when 
stimulated by UPEC (69, 71 ). During gram negative septicemia, these proinflammatory 
cytokines, like tumor necrosis factor (TNF) and IL-6, activates the inflammatory cascade 
and trigger the systemic infection (72). So we assessed the role of cytokine responses of 
human ureter uroepithelial cell line SV-HUC1 cells to whole bacterial cells and LPS by 
quantitative real time PCR (Table 14). Both intact bacterial cells and LPS stimulated the 
mRNA expression of proinflammatory cytokines, including TNF-α, ΙL-6 and IL-8.  The 
expression levels of TNF-α, ΙL-6 and IL-8 were higher in cells stimulated with intact 
bacterial cells than in cells stimulated with LPS. The wild type bacteria and its LPS 
resulted in highest expression of both cytokine and chemokine, while the cells treated 
with uvrY mutant bacteria has lowered TNF-α, IL-6, and IL-8 expression by ~ 4, 5 and 9-
fold.   The cells treated with purified LPS from uvrY mutant also down-regulated the 
cytokines TNF-α and IL-6 by ~ 3-fold. The uvrY/p-uvrY complemented strain restored 
the phenotype like that of wild type. Although the csrA mutant had the highest level of 
LPS (2080 ng/μl) from equal number of cells, cells treated with equal amount of LPS 
(10ng/μl) did not stimulated the expression of cytokines like that of wild type (Table 14). 
This may explain that there is a difference in the LPS pattern (Figure 8) which accounts 
for the lowered expression of the cytokines. It indicates that uvrY and csrA may affect 




csrA may affect synthesis and probably transport. Also, stimulating with csrA mutant 
bacteria strain had similar effect on expression of cytokines. Our result suggests that uvrY 
mutant is less virulent than all other strains and BarA-UvrY TCS may be a global 





















Table 14. Mutation in uvrY gene in CFT073 strain leads to lower cytokine and chemokine expression as detected by quantitative real-
time PCR  
 
Fold change in mRNA levels. SV-HUC1 ureter cells treated with 
Purified LPS (10 ng)                           Whole bacterial cells Genotype 
TNFα IL6 IL8 TNFα IL6 IL8 




































The values are mean ± SD of the mean for two independent experiments with triplicate samples. The downward arrow indicates down 







3.2.2. Role of LuxS in determining virulence in E. coli CFT073 
3.2.2.1. Mutation in luxS reduces lethality in chicken embryo lethality assay 
In our laboratory the mouse UTI assays showed that mutation in luxS reduced the 
virulence than that of wild type. We looked for viable alternate for mouse UTI to 
determine the virulence determinants. The virulence of BarA-UvrY TCS of avian 
pathogenic E. coli strain χ7122 was shown using chicken embryo lethality assay (42). 
Here we tried to demonstrate the chicken embryo lethality assay as a surrogate model for 
in vivo mouse UTI. The virulence was determined using chicken embryo lethality assay 
by the number of embryos killed within a given period of time. By 72 h post inoculation, 
all the embryos infected with wild type strain were dead, whereas mutation in luxS 
reduced virulence by 58% (7 out of 12 embryos were dead) after 7 days post inoculation. 
The reduction in virulence was significant (P<0.01) (Figure 9). Complementation of luxS 
in plasmid restored the virulence to 91%. Mutation in hlyD (hemolysin gene) also 
reduced the virulence to 50% and complementation of hlyD in plasmid restored the effect 





























□ = CFT073, ■ = luxS, ◊ = luxS/p-luxS, ∆ = hlyD, ▲ = hlyD/p-hlyD ● = DH5αK-12.  
The lethality was determined by inoculating 0.1 ml of 5 x 103 CFU of  bacteria into the 
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3.2.2.2. Mutation in luxS reduces the invasion to cultured ureter uroepithelial cells 
The role of luxS in mediating attachment and invasion in cultured uroepithelial 
cells was investigated by using standard gentamicin protection assays (46). Attachment 
and invasion abilities of mutant luxS bacteria compared to that of wild type were 
unaltered in cultured urinary bladder (HTB-9) epithelial cells (Table 15). However, 
mutation in luxS reduced the invasion abilities by one log (~ 10 fold) in cultured ureter 
(SV-HUC1) epithelial cells (Table 16). The attachment of the bacteria was unaltered and 
there was no significant difference. Expression of luxS in trans in plasmid pBR322 
restored the invasion abilities in cultured ureter (SV-HUC1) cells as that of wild type.  
 
3.2.2.3. Mutation in luxS reduces the cytotoxic effect to cultured human kidney cells 
Mutation in luxS reduces the cytotoxic effects of the bacterial supernatants on 
cultured human kidney HK-2 cells. The suitable time point for reading the assay was 
closely evaluated (data not given), and found to be 180 minutes after the addition of 
WST-1 reagent into the infected cells (Table 17 and Figure 10). The growth was inhibited 
80 % in wild type, while mutation in luxS and hlyD reduced the cytotoxic effects; the 
growth was inhibited 65 % and 62 % respectively relative to the control.  The reduction 
in the cytotoxicity was significant for both luxS (P<0.05) and hlyD (P≤ 0.01) mutant 
compared to the wild type (Table 17). Complementation of the genes in plasmid restored 






Table 15. Attachment and invasion of E. coli CFT073 strain to cultured Urinary bladder uroepithelial cells  
Relevant 
genotype 
Initial cells a      
(log10 CFU  
ml-1) 
Attached and 
invaded after 2ha  
(log10 CFU ml-1) 
Invaded fraction 
surviving after 4ha  
(log 10 CFU ml-1) 
Calculated 
attached 






Wild type 8.8 ± 0.9  7.0 ± 0.8  3.6 ± 0.5 7.0 ± 0.8 1.4 × 10-2 4.4 × 10-4 
luxS 8.7 ± 0.9 7.0 ± 0.8  3.2 ± 0.5 7.0 ± 0.8 2.0 × 10-2 1.7 × 10-4 
luxS/p-luxS 7.9 ± 0.9 6.8± 0.8 3.7 ±  0.5 6.8 ± 0.8 7.5 × 10-2 9.0 × 10-4 
 












Table 16. Mutation in luxS reduces invasion of E. coli CFT073 strain to cultured Ureter uroepithelial cells 
Relevant 
genotype 




invaded after 2h a  
(log10 CFU ml-1) 
Invaded fraction 
surviving after 4h a 
(log 10 CFU ml-1) 
Calculated 
attached 






Wild type 8.6 ± 0.9  7.4 ± 0.8  3.3 ± 0.5 7.5 ± 0.9 7.5 × 10-2 6.7 × 10-5 
luxS 8.7 ± 0.9 7.4 ± 0.9  2.1 ± 0.3 7.4 ± 0.9 4.6 × 10-2 5.6 × 10-6 
luxS/p-luxS 8.3 ± 0.9 7.1 ± 0.8 3.8 ±  0.6 7.1 ± 0.8 6.0 × 10-2 5.0 × 10-4 
 












Figure 10. Mutation in luxS reduces the cytotoxic effect to cultured human kidney cells 
                
Figure 10. Phase-contrast photomicrographs of human kidney control (HK-2 cells) (A), 6 
hours after treating cells with supernatants of CFT073 wild type (B), hlyD (C), hlyD/p-






Table 17.  Mutation in luxS reduces cytotoxic effects on cultured human kidney cells   
Genotype Percentage of survival (relative to control) 
Control 100 
CFT073 wild type  20 ± 2 
hlyD      38 ± 3** 
hlyD/p-hlyD  24 ± 3 
luxS    36 ± 2* 
luxS/p-luxS  23 ± 2 
 
Data obtained from three independent experiments with 6 replicates per condition. (*, p < 


















3.2.2.4. Mutation in luxS causes growth defect in artificial urine medium 
Mutation in luxS reduced the virulence in the mouse model, chicken embryo 
lethality assay, cytotoxicity of the HK-2 cells and reduced the invasion abilities in SV-
HUC1 cells. Consequently, we examined for the virulence factors that are responsible for 
the reduction in the virulence. We examined for differences in virulence factors in the 
bacterial culture supernatant, differences in lipopolysaccharide and for growth defects in 
the artificial urine medium. The bacterial pathogen causing urinary tract infection has to 
grow in human urine. Urine is a variable fluid and its composition varies between 
individuals and in the same individual over time (63). The composition of the urine varies 
by fluid intake, exercise, ambient temperature and diet. The pH can vary from 4.5 to 8 
(64). To avoid the variations found in the human urine over time, a simple artificial urine 
medium having mid-point values for each component is used to determine the growth 
properties of the bacteria. The bacteria were grown in filter sterilized artificial urine 
medium (pH 6.5). When compared with the wild type the generation time of the luxS 
mutant bacteria was increased in the exponential phase (Table 18). However, all the 
bacterial strains reached almost the same OD in the stationary phase (data not given).  
The growth defect of the mutant bacteria observed during the exponential phase may 








3.2.2.5. Mutation in luxS alters the secreted protein Hemolysin and Pap  
 Since the luxS mutant showed decreased virulence in mouse model, chicken 
embryo killing and cytotoxicity to cultured HK-2 cells, we compared the secreted protein 
profile in culture supernatant to identify the virulence determinants of luxS mutant to that 
of wild type bacteria. The protein profiles of these filtered bacterial culture supernatant 
were identified in 4-20 % Tris-Glycine gradient SDS-PAGE gel.  The bands of the 
interest were excised and subjected to mass spectrometric analysis. Two bands of 
approximately 110 kDa and 16.5 kDa were found to be Hemolysin and Pap protein by 
protein BLAST analysis. Hemolysin is a cytotoxic protein and decrease in the hemolytic 
activity of luxS mutant was correlated with its decreased virulence on cultured HK- cells, 
chicken embryo killing and in mouse UTI. The UPEC bacteria express its virulence 
factors and colonize in the bladder, causing cystitis or in the kidney resulting in 
pyelonephritis. The exotoxin Hly is one of the virulence factors associated with 
pathogenesis and the attachment organelle Pap pili helps in colonizing the uroepithelial 
tissues (73, 74). The production of hemolysin protein contributes to the virulence of 
extra-intestinal pathogenic E. coli infections (65, 49). Mutation in luxS resulted in partial 
reduction in virulence as reported by Sperandio et al., (36), Stroeher et al., (59) and 
Sircili et al., (37). Both 110 kDa hemolysin protein (HlyA) (66, 67) and 16.5 kDa PapA 
protein (75) were down regulated in the mutant compared to wild type. We investigated 
the role of the activity of hemolysin protein obtained from filtered bacterial culture 
supernatant grown in artificial urine medium against sheep erythrocytes at 30.5ºC for 7 h. 




different (p < 0.01). There was more than 3-fold decrease in hemolysis activity in the 
mutant luxS (Table 18). Complementation of luxS in plasmid restored the hemolytic 
activity similar to wild type. The decreased exotoxin HlyA activity contributed to the 
reduction in the virulence of mutant bacteria.  The hemolytic activity of the cultured 
bacterial supernatant contributes to the reduced cytotoxic effects against cultured human 
kidney HK-2 cells. P pilus is one of the critical factors in causing urinary tract infections 
(76). Although the attachment of the luxS mutant bacteria to the cultured uroepithelial 
tissue was not affected, its invasion was reduced in cultured SV-HUC1 ureter cells. This 
reduction may be due to the down regulation of the Pap protein, as detected in SDS-
















Table 18. Mutation in luxS increases the generation time during exponential phase and 
decreases hemolysis of sheep erythrocytes in coculture with bacterial culture supernatant 
grown in artificial urine medium  
Genotype Generation time (min) a Hemolysis of sheep erythrocytes (OD 405) a 
CFT073 wild type 101.06 ± 3.01 2.6 ± 0.14 
hlyD 198.6 ± 4.14 0.55 ± 0.08 
hlyD/p-hlyD 130.84 ± 2.32 10.6 ± 0.18 
luxS 154.55 ± 2.15* 0.7 ± 0.12** 
luxS/p-luxS 124.77 ± 3.42 2.4 ± 0.10 
 
aData obtained from mean values ± standard deviations from three different experiments. 
















Figure 11. Protein profiles of wild type and luxS mutant bacteria 
 
Figure 11. Protein samples were separated by 4 to 20% SDS-PAGE and stained with Coomassie blue and protein bands of interest 
analyzed by MS analysis.                                       
                                 74  
 
  
3.2.2.6. Mutation in luxS alters Lipopolysaccharide profile   
 We investigated the role of lipopolysaccharide in pathogenesis. LPS is a 
potent endotoxin responsible for gram negative septicemia (61) and responsible for 
the production of variety of proinflammatory cytokines followed by septic shock and 
disseminated intravascular coagulation of the infected animals (62). Quantification of 
the LPS with densitometry assay was done by comparing with standard E. coli LPS. 
We found that from a given number of E. coli cells (4 x 109) there was partial 
reduction in LPS of the luxS mutant strain (605 ng/μl) as compared to the wild type 
(758 ng/μl). This partial reduction in the LPS may also contribute to reduction in 
virulence. Thus, our results showed that LuxS may contribute to the virulence 
determinants of the UPEC bacteria and the virulence determinants are multifactorial 












Using a chicken embryo lethality assay, we have shown that BarA-UvrY TCS 
regulates virulence factors in APEC serotype O78:K80:H9. A combination of 
virulence determinants, such as the abilities to adhere, invade, and survive within 
antigen-presenting cells, such as macrophages are compromised in mutants lacking 
either barA and uvrY genes. The ability to persist within macrophages provides a 
survival advantage to APEC strains by potentiating efficient replication while 
abrogating elimination by the host immune responses. This was evident in our 
chicken embryo lethality assay, where isogenic mutant strains were rapidly eliminated 
from the livers and spleens of the infected embryos, while the wild-type APEC strain 
persisted within tissues, causing mortality. Our results also indicate that 12-day-old 
SPF chicken embryos can be used as a model to determine the initial virulence 
properties of APEC strains conveniently, since the mortality and colonization results 
of the wild-type strain are similar to those of 3.5-week-old chickens (54). Our results, 
therefore, suggest that BarA-UvrY TCS may be a global regulator of APEC virulence.  
In this study, mutation of luxS in APEC serotype O78:K80:H9 leads to partial 
reduction in the virulence of the bacteria. The virulence of the bacteria in chicken 
embryo lethality assay was compromised and the abilities to invade and persist in the 
internal organs like liver and spleen are reduced in the luxS mutant bacteria. The 
adherence to cultured chicken embryo fibroblast and chicken macrophage cells was 




LuxS quorum sensing signaling system leads to the defect in assembly and transport 
of the LPS contributing to the reduced virulence of the APEC strain.  
In Uropathogenic E. coli CFT073, mutating either barA or uvrY reduces 
virulence in chicken embryo lethality assay. A number of virulence determining 
factors like ability to invade ureter uroepithelial cells, cytotoxicity to cultured human 
kidney cells and ability to grow in artificial urine medium during exponential phase 
are compromised in barA or uvrY mutant bacteria. The contributing factors for 
reduction in the virulence was due to the downregulation of secreted exotoxin 
hemolysin, alteration in LPS pattern and downregulation of proinflammatory 
cytokines TNF-α, IL-6 and chemokine IL-8 in mutant bacteria lacking uvrY gene. 
Our results suggest that mutation in transcriptional activator UvrY leads to reduction 
in virulence and BarA-UvrY TCS is a global regulator of virulence in UPEC CFT073.  
The mutation of luxS in UPEC CFT073 leads to partial reduction in virulence 
in chicken embryo lethality assay, reduces invasion ability to ureter uroepithelial 
cells, and decreases cytotoxic effect to human kidney cells. The mutant luxS bacteria 
had a growth defect in the artificial urine medium leading to decreased fitness. The 
exoprotein like hemolysin and adhesion protein PapA in the supernatant was reduced. 
The reduced quantity of LPS also contributes to the reduced virulence. Thus, our 






1. Le Bouguenec C. 2005. Adhesins and invasins of pathogenic Escherichia coli. 
Int J Med Microbiol 295: 471-8 
2. Ewers C, Li G, Wilking H, Kiessling S, Alt K, Antao EM, Laturnus C, Diehl 
I, Glodde S, Homeier T, Bohnke U, Steinruck H, Philipp HC, Wieler LH. 
2007. Avian pathogenic, uropathogenic, and newborn meningitis-causing 
Escherichia coli: how closely related are they? Int J Med Microbiol 297: 163-
76 
3. Gross WB. 1991. Coliobacillosis, p. 138-144. In B. W. Calnek, H. J. Barnes, 
C. W. Beard, W. M. Reid, and H. W. Yoder, Jr. (ed.), Diseases of poultry. 9th 
ed. Iowa State University Press, Ames, Iowa.  
4. Barnes HJ, S. S. Vaillancourt, and W. G. Gross. . 2003. Colibacillosis, p. 631-
652. In Y. M. Saif (ed.), Diseases of poultry. . Iowa State University Press, 
Ames.  
5. Norton RA. 1997. Avian cellulitis. World's Poult. Sci 53: 337-49 
6. Gross WB. 1961. Development of airsac disease. Avian Dis 5: 431-9 
7. Gross WB. 1994. Disease due to Escherichia coli in poultry, p. 237-259. In C. 
L. Gyles (ed.), Escherichia coli in domestic animals and man. CAB 
International. Wallingford, United Kingdom  
8. Nicolle LE. 2001. Epidemiology of Urinary Tract Infections. Infect Med 18: 
153-62 




morbidity, and economic costs. Am J Med 113 Suppl 1A: 5S-13S 
10. Hooton TM, Stamm WE. 1997. Diagnosis and treatment of uncomplicated 
urinary tract infection. Infect Dis Clin North Am 11: 551-81 
11. Zhang L, Foxman B. 2003. Molecular epidemiology of Escherichia coli 
mediated urinary tract infections. Front Biosci 8: e235-44 
12. Brumfitt W, Gargan RA, Hamilton-Miller JM. 1987. Periurethral 
enterobacterial carriage preceding urinary infection. Lancet 1: 824-6 
13. Johnson JR. 1991. Virulence factors in Escherichia coli urinary tract infection. 
Clin Microbiol Rev 4: 80-128 
14. Russo TA, Johnson JR. 2000. Proposal for a new inclusive designation for 
extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 
181: 1753-4 
15. Robinson VL, Buckler DR, Stock AM. 2000. A tale of two components: a 
novel kinase and a regulatory switch. Nat Struct Biol 7: 626-33 
16. Stock AM, Robinson VL, Goudreau PN. 2000. Two-component signal 
transduction. Annu Rev Biochem 69: 183-215 
17. Ishige K, Nagasawa S, Tokishita S, Mizuno T. 1994. A novel device of 
bacterial signal transducers. Embo J 13: 5195-202 
18. Mizuno T. 1997. Compilation of all genes encoding two-component 
phosphotransfer signal transducers in the genome of Escherichia coli. DNA 
Res 4: 161-8 




induction of the conserved alternative sigma factor RpoS in Escherichia coli is  
dependent on BarA, a probable two-component regulator. Mol Microbiol 37: 
371-81 
20. Mukhopadhyay S, Schellhorn HE. 1997. Identification and characterization of 
hydrogen peroxide-sensitive mutants of Escherichia coli: genes that require 
OxyR for expression. J Bacteriol 179: 330-8 
21. Goodier RI, Ahmer BM. 2001. SirA orthologs affect both motility and 
virulence. J Bacteriol 183: 2249-58 
22. Parkins MD, Ceri H, Storey DG. 2001. Pseudomonas aeruginosa GacA, a 
factor in multihost virulence, is also essential for biofilm formation. Mol 
Microbiol 40: 1215-26 
23. Pernestig AK, Melefors O, Georgellis D. 2001. Identification of UvrY as the 
cognate response regulator for the BarA sensor kinase in Escherichia coli. J 
Biol Chem 276: 225-31 
24. Teplitski M, Goodier RI, Ahmer BM. 2003. Pathways leading from 
BarA/SirA to motility and virulence gene expression in Salmonella. J 
Bacteriol 185: 7257-65 
25. Gryllos I, Levin JC, Wessels MR. 2003. The CsrR/CsrS two-component 
system of group A Streptococcus responds to environmental Mg2+. Proc Natl 
Acad Sci U S A 100: 4227-32 
26. Lawhon SD, Maurer R, Suyemoto M, Altier C. 2002. Intestinal short-chain 




virulence through BarA/SirA. Mol Microbiol 46: 1451-64 
27. Prouty AM, Gunn JS. 2000. Salmonella enterica serovar typhimurium 
invasion is repressed in the presence of bile. Infect Immun 68: 6763-9 
28. Altier C, Suyemoto M, Ruiz AI, Burnham KD, Maurer R. 2000. 
Characterization of two novel regulatory genes affecting Salmonella invasion 
gene expression. Mol Microbiol 35: 635-46 
29. Suzuki K, Wang X, Weilbacher T, Pernestig AK, Melefors O, Georgellis D, 
Babitzke P, Romeo T. 2002. Regulatory circuitry of the CsrA/CsrB and 
BarA/UvrY systems of Escherichia coli. J Bacteriol 184: 5130-40 
30. Wei BL, Brun-Zinkernagel AM, Simecka JW, Pruss BM, Babitzke P, Romeo 
T. 2001. Positive regulation of motility and flhDC expression by the RNA-
binding protein CsrA of Escherichia coli. Mol Microbiol 40: 245-56 
31. Heeb S, Haas D. 2001. Regulatory roles of the GacS/GacA two-component 
system in plant-associated and other gram-negative bacteria. Mol Plant 
Microbe Interact 14: 1351-63 
32. Wong SM, Carroll PA, Rahme LG, Ausubel FM, Calderwood SB. 1998. 
Modulation of expression of the ToxR regulon in Vibrio cholerae by a 
member of the two-component family of response regulators. Infect Immun 
66: 5854-61 
33. De Keersmaecker SC, Sonck K, Vanderleyden J. 2006. Let LuxS speak up in 
AI-2 signaling. Trends Microbiol 14: 114-9 




Microbiol 55: 165-99 
35. Federle MJ, Bassler BL. 2003. Interspecies communication in bacteria. J Clin 
Invest 112: 1291-9 
36. Sperandio V, Mellies JL, Nguyen W, Shin S, Kaper JB. 1999. Quorum 
sensing controls expression of the type III secretion gene transcription and 
protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli. 
Proc Natl Acad Sci U S A 96: 15196-201 
37. Sircili MP, Walters M, Trabulsi LR, Sperandio V. 2004. Modulation of 
enteropathogenic Escherichia coli virulence by quorum sensing. Infect Immun 
72: 2329-37 
38. Winzer K, Sun YH, Green A, Delory M, Blackley D, Hardie KR, Baldwin TJ, 
Tang CM. 2002. Role of Neisseria meningitidis luxS in cell-to-cell signaling 
and bacteremic infection. Infect Immun 70: 2245-8 
39. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. 2002. 
Quorum-sensing regulators control virulence gene expression in Vibrio 
cholerae. Proc Natl Acad Sci U S A 99: 3129-34 
40. Balestrino D, Haagensen JA, Rich C, Forestier C. 2005. Characterization of 
type 2 quorum sensing in Klebsiella pneumoniae and relationship with biofilm 
formation. J Bacteriol 187: 2870-80 
41. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. 2003. Bacteria-host 





42. Herren CD, Mitra A, Palaniyandi SK, Coleman A, Elankumaran S, 
Mukhopadhyay S. 2006. The BarA-UvrY two-component system regulates 
virulence in avian pathogenic Escherichia coli O78:K80:H9. Infect Immun 74: 
4900-9 
43. Provence DL, Curtiss R, 3rd. 1992. Role of crl in avian pathogenic 
Escherichia coli: a knockout mutation of crl does not affect hemagglutination 
activity, fibronectin binding, or Curli production. Infect Immun 60: 4460-7 
44. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell 
CV, Jones BD, Warren JW. 1990. Pyelonephritogenic Escherichia coli and 
killing of cultured human renal proximal tubular epithelial cells: role of 
hemolysin in some strains. Infect Immun 58: 1281-9 
45. Nolan LK, Wooley RE, Brown J, Spears KR, Dickerson HW, Dekich M. 
1992. Comparison of a complement resistance test, a chicken embryo lethality 
test, and the chicken lethality test for determining virulence of avian 
Escherichia coli. Avian Dis 36: 395-7 
46. Elsinghorst EA. 1994. Measurement of invasion by gentamicin resistance. 
Methods Enzymol 236: 405-20 
47. Brooks T, Keevil CW. 1997. A simple artificial urine for the growth of 
urinary pathogens. Lett Appl Microbiol 24: 203-6 
48. Todar K. Textbook of Bacteriology, 
http://textbookofbacteriology.net/growth.html.  




conferring quantitative differences in virulence. Infect Immun 43: 156-60 
50. Gleason TG, Houlgrave CW, May AK, Crabtree TD, Sawyer RG, Denham W, 
Norman JG, Pruett TL. 1998. Hemolytically active (acylated) alpha-
hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of 
Escherichia coli by an IL-1- and tumor necrosis factor-independent 
mechanism. Infect Immun 66: 4215-21 
51. Biswas S, Biswas I. 2006. Regulation of the glucosyltransferase (gtfBC) 
operon by CovR in Streptococcus mutans. J Bacteriol 188: 988-98 
52. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among 
Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide 
gels. J Bacteriol 154: 269-77 
53. Ngeleka M, Kwaga JK, White DG, Whittam TS, Riddell C, Goodhope R, 
Potter AA, Allan B. 1996. Escherichia coli cellulitis in broiler chickens: clonal 
relationships among strains and analysis of virulence-associated factors of 
isolates from diseased birds. Infect Immun 64: 3118-26 
54. Mellata M, Dho-Moulin M, Dozois CM, Curtiss R, 3rd, Brown PK, Arne P, 
Bree A, Desautels C, Fairbrother JM. 2003. Role of virulence factors in 
resistance of avian pathogenic Escherichia coli to serum and in pathogenicity. 
Infect Immun 71: 536-40 
55. Schaefer-Klein J, Givol I, Barsov EV, Whitcomb JM, VanBrocklin M, Foster 
DN, Federspiel MJ, Hughes SH. 1998. The EV-O-derived cell line DF-1 




vectors. Virology 248: 305-11 
56. Mellata M, Dho-Moulin M, Dozois CM, Curtiss R, 3rd, Lehoux B, 
Fairbrother JM. 2003. Role of avian pathogenic Escherichia coli virulence 
factors in bacterial interaction with chicken heterophils and macrophages. 
Infect Immun 71: 494-503 
57. Toth TE, Siegel P, Veit H. 1987. Cellular defense of the avian respiratory 
system. Influx of phagocytes: elicitation versus activation. Avian Dis 31: 861-
7 
58. Pourbakhsh SA, Boulianne M, Martineau-Doize B, Fairbrother JM. 1997. 
Virulence mechanisms of avian fimbriated Escherichia coli in experimentally 
inoculated chickens. Vet Microbiol 58: 195-213 
59. Stroeher UH, Paton AW, Ogunniyi AD, Paton JC. 2003. Mutation of luxS of 
Streptococcus pneumoniae affects virulence in a mouse model. Infect Immun 
71: 3206-12 
60. Ficken MD, Barnes HJ. 1989. Acute airsacculitis in turkeys inoculated with 
Pasteurella multocida. Vet Pathol 26: 231-7 
61. Hurley JC. 1995. Endotoxemia: methods of detection and clinical correlates. 
Clin Microbiol Rev 8: 268-92 
62. Morrison DC, Ryan JL. 1987. Endotoxins and disease mechanisms. Annu Rev 
Med 38: 417-32 




mammals. Part 1: Man. In: Blood and Other Bodily Fluids (Dittmer, D. S., 
Ed.) pp. 363-369.   Washington, DC: Federation of American Societies for 
Experimental Biology 
64. Guyton AC. 1981. Textbook of medical physiology, p.457. Philadelphia: 
W.B. Saunders 
65. Welch RA, Dellinger EP, Minshew B, Falkow S. 1981. Haemolysin 
contributes to virulence of extra-intestinal E. coli infections. Nature 294: 665-
7 
66. Felmlee T, Pellett S, Welch RA. 1985. Nucleotide sequence of an Escherichia 
coli chromosomal hemolysin. J Bacteriol 163: 94-105 
67. Mackman N, Nicaud JM, Gray L, Holland IB. 1985. Genetical and functional 
organisation of the Escherichia coli haemolysin determinant 2001. Mol Gen 
Genet 201: 282-8 
68. Backhed F, Soderhall M, Ekman P, Normark S, Richter-Dahlfors A. 2001. 
Induction of innate immune responses by Escherichia coli and purified 
lipopolysaccharide correlate with organ- and cell-specific expression of Toll-
like receptors within the human urinary tract. Cell Microbiol 3: 153-8 
69. Agace WW, Hedges SR, Ceska M, Svanborg C. 1993. Interleukin-8 and the 
neutrophil response to mucosal gram-negative infection. J Clin Invest 92: 780-
5 
70. Hedges S, Anderson P, Lidin-Janson G, de Man P, Svanborg C. 1991. 




with gram-negative bacteria. Infect Immun 59: 421-7 
71. Hedges S, Agace W, Svensson M, Sjogren AC, Ceska M, Svanborg C. 1994. 
Uroepithelial cells are part of a mucosal cytokine network. Infect Immun 62: 
2315-21 
72. Hedlund M, Wachtler C, Johansson E, Hang L, Somerville JE, Darveau RP, 
Svanborg C. 1999. P fimbriae-dependent, lipopolysaccharide-independent 
activation of epithelial cytokine responses. Mol Microbiol 33: 693-703 
73. Emody L, Kerenyi M, Nagy G. 2003. Virulence factors of uropathogenic  
Escherichia coli. Int J Antimicrob Agents 22 Suppl 2: 29-33 
74. Mansson LE, Melican K, Boekel J, Sandoval RM, Hautefort I, Tanner GA, 
Molitoris BA, Richter-Dahlfors A. 2007. Real-time studies of the progression 
of bacterial infections and immediate tissue responses in live animals. Cell 
Microbiol 9: 413-24 
75. Garofalo CK, Hooton TM, Martin SM, Stamm WE, Palermo JJ, Gordon JI, 
Hultgren SJ. 2007. Escherichia coli from urine of female patients with urinary 
tract infections is competent for intracellular bacterial community formation. 
Infect Immun 75: 52-60 
76. Roberts JA, Marklund BI, Ilver D, Haslam D, Kaack MB, Baskin G, Louis M, 
Mollby R, Winberg J, Normark S. 1994. The Gal(alpha 1-4)Gal-specific tip 
adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in 





77. Datsenko, KA, Wanner BL. 2000. One-step inactivation of chromosomal 
genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 
97: 6640-5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
